Pathstone Holdings
ITCI

Pathstone Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Pathstone Holdings’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,380
Closed -$1.63M – 2361
2025
Q1 		$1.63M Sell
12,380
-118
-0.9% -$14.7K 0.01% 1100
2024
Q4 		$1.04M Buy
12,498
+25
+0.2% +$2.05K ﹤0.01% 1349
2024
Q3 		$913K Buy
12,473
+207
+2% +$15.6K ﹤0.01% 1416
2024
Q2 		$840K Buy
12,266
+587
+5% +$40.7K ﹤0.01% 1420
2024
Q1 		$808K Buy
11,679
+4,996
+75% +$343K ﹤0.01% 1419
2023
Q4 		$479K Buy
+6,683
New +$384K ﹤0.01% 1529

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return